1. Home
  2. GEMI vs MDXG Comparison

GEMI vs MDXG Comparison

Compare GEMI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gemini Space Station Inc.

GEMI

Gemini Space Station Inc.

SELL

Current Price

$4.13

Market Cap

666.3M

Sector

N/A

ML Signal

SELL

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

SELL

Current Price

$4.83

Market Cap

672.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
GEMI
MDXG
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
666.3M
672.8M
IPO Year
2025
2007

Fundamental Metrics

Financial Performance
Metric
GEMI
MDXG
Price
$4.13
$4.83
Analyst Decision
Hold
Strong Buy
Analyst Count
10
5
Target Price
$5.17
★ $7.40
AVG Volume (30 Days)
★ 2.3M
1.1M
Earning Date
11-09-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.86
14.29
EPS
N/A
★ N/A
Revenue
$179,572,000.00
★ $418,630,000.00
Revenue This Year
$2.62
N/A
Revenue Next Year
$22.07
$21.78
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 26.31
19.99
52 Week Low
$3.39
$3.03
52 Week High
$23.30
$7.97

Technical Indicators

Market Signals
Indicator
GEMI
MDXG
Relative Strength Index (RSI) 37.76 64.55
Support Level $4.00 $4.37
Resistance Level $5.02 $4.99
Average True Range (ATR) 0.30 0.17
MACD -0.15 -0.01
Stochastic Oscillator 2.84 74.58

Price Performance

Historical Comparison
GEMI
MDXG

About GEMI Gemini Space Station Inc.

Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: